Related Experiment Video
Updated: May 20, 2026
06:32
Isolation, Enrichment, and Maintenance of Medulloblastoma Stem Cells
Published on: September 1, 2010
Subgroup-specific structural variation across 1,000 medulloblastoma genomes
Paul A Northcott1, David J H Shih, John Peacock
1Developmental & Stem Cell Biology Program, The Hospital for Sick Children, Toronto, Ontario M5G 1L7, Canada.
Nature
|July 27, 2012
Summary
This study analyzed somatic copy number aberrations (SCNAs) in 1,087 medulloblastomas. Findings reveal subgroup-specific genetic alterations, identifying potential targets for novel, targeted pediatric brain tumor therapies.
Area of Science:
- Neuro-oncology
- Genomics
- Pediatric oncology
Background:
- Medulloblastoma is the most common malignant pediatric brain tumor.
- Current treatments involve non-specific cytotoxic therapies.
- Tumor heterogeneity and small sample sizes have limited previous targeted therapy research.
Purpose of the Study:
- To investigate somatic copy number aberrations (SCNAs) across a large cohort of medulloblastomas.
- To identify subgroup-enriched genetic alterations for targeted therapy development.
- To explore potential therapeutic targets within distinct medulloblastoma molecular groups.
Main Methods:
- Analysis of somatic copy number aberrations (SCNAs) in 1,087 unique medulloblastoma samples.
- Subgroup enrichment analysis of identified SCNAs.
- Identification of recurrent translocation events and copy number gains.
Main Results:
- SCNAs are prevalent in medulloblastoma and enriched within specific molecular subgroups.
- A tandem duplication of SNCAIP (a Parkinson's disease-associated gene) is frequent in Group 4α.
- Recurrent PVT1 translocations (PVT1-MYC, PVT1-NDRG1) via chromothripsis are specific to Group 3.
- Targetable SCNAs involving TGF-β signaling (Group 3) and NF-κB signaling (Group 4) were identified.
Conclusions:
- Medulloblastoma exhibits significant subgroup-specific SCNA profiles.
- Identified SCNAs, such as SNCAIP duplication and PVT1 translocations, offer subgroup-specific biomarkers.
- Targetable signaling pathways present promising avenues for developing rational, subgroup-specific therapies for medulloblastoma.
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
01:20The Retinoblastoma Gene
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...